Effect of aerosol delivery system and formulation on nebulized budesonide output

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 10, Issue 4, 1997, Pages 307-318

  Berlinski, Ariel ^a   Waldrep, J Clifford ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aerosol; Budesonide; Liposomes; Nebulizers; Suspensions

Indexed keywords

BUDESONIDE; GLUCOCORTICOID;

AEROSOL; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; PARTICLE SIZE;

EID: 0031436033     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1997.10.307     Document Type: Article

References (44)

1. Pedersen, S. 1994. Choice of inhalation therapy in paediatrics. Eur. Respir. Rev. 4:(18) 85-88.
2. Sly, P.D., and P.N. Le Souef. 1991. Inhaled therapy in paediatrics. J. Paediatr. Child. Health 27:7-10.
3. Godfrey, S., A. Avital, A. Rosler, and K. Uwyyed. 1987. Nebulized Budesonide in severe infantile asthma. Lancet ii:851-852.
4. Hulquist, C. 1989. Nebulized Budesonide in severe childhood asthma. Lancet I:379-380.
5. De Jongste, J.C., and E.J. Duiverman. 1989. Nebulized Budesonide in severe childhood asthma. Lancet I:1388.
6. Van Bever, H.P., L. Schuddink, M. Wojciechowski, and W.J. Stevens. 1990. Aerosolized Budesonide in asthmatic infants: a double blind study. Pediatr. Pulmonol. 9:177-180.
7. Ilangovan, P., S. Pedersen, S. Godfrey, K. Nikander, N. Noviski, and J.O. Warner. 1993. Treatment of severe steroid dependent preschool asthma with nebulized Budesonide suspension. Arch. Dis. Child. 68:356-359.
8. Wennergren, G., S.L. Nordvall, G. Hedlin, C. Moller, S. Wille, and E. Asbrink Nilsson. 1996. Nebulized Budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatr. 85:183-189.
9. Cameron, D., M. Clay, and Silverman, M. 1990. Evaluation of nebulizers for use in neonatal ventilator circuits. Crit. Care Med. 18:866-870.
10. Lodrup Carlsen, K.C., K. Nikander, and K.-H. Carlsen. 1992. How much nebulized Budesonide reaches infants and toddlers? Arch. Dis. Child. 67:1077-1079.
11. Arnon, S., J. Grigg, K. Nikander, and M. Silverman. 1992. Delivery of micronized Budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Pediatr. Pulmonol. 13:172-175.
12. Nikander, K. 1994. Drug delivery systems. J. Aerosol Med. 7(Suppl 1):S19-S24.
13. Waldrep, J.C., P.W. Scherer, and V. Knight. 1993. Experimental lung therapy using drug-liposome aerosols. Am. Rev. Resp. Dis. 147(4, Part 2 of 2):A289.
14. Taylor, K.M.G., and S.J. Farr. 1993. Liposomes for drug delivery to the respiratory tract. Drug Development and Industrial Pharmacy 19(1&2):123-142.
15. Lasic, D.D., and D.P. Papahadjopoulos. 1995. Liposomes revisited. Science 267:1275-1276.
16. Gonzalez-Rothi, R.J., and H. Shreier. 1995. Pulmonary delivery of liposome-encapsulated drugs in asthma therapy. Clin. Immunother. 4(5):331-337.
17. Waldrep, J.C., P.W. Scherer, G. Dale Hess, M. Black, and V. Knight. 1994. Nebulized glucocorticoids in liposomes: Aerosol characteristics and human dose estimates. J. Aerosol Med. 7(2):135-145.
18. O'Riordan, T.G., J.C. Waldrep, W.M. Abraham, Y. Mao, J.R. Sabater, M. Sieiczak, and V. Knight. 1997. Delivery of nebulized Budesonide liposomes to the respiratory tract of allergic sheep. J. Aerosol Med. 10(2):117-128.
19. Newnham, D.M., and B.J. Lipworth. 1994. Nebuliser performance, pharmacokinetics, airways and systemic effects of Salbutamol given via a novel nebuliser delivery system ("Ventstream). Thorax 49(8):762-770.
20. Vadiei, K., R. Perez-Soler, and D.R. Luke. 1989. In vitro evaluation of liposomal Cyclosporin. Int. J. Pharm. 57:133-138.
21. Waldrep, J.C., P.W. Scherer, K. Keyhani, and V. Knight. 1993. Cyclosporin A liposome aerosol: Particle size and calculated respiratory deposition. Int. J. Pharm. 97:205-212.
22. Edman, P. 1994. Pharmaceutical formulations-suspensions and solutions. J. Aerosol Med. 7(suppl 1):S3-S6.
23. Hallworth, G.N., and U.G. Andrews. 1976. Size analysis of suspension inhalation by inertial separation methods. J. Pharm. Pharmacol. 28:898-907.
24. Nilsson, G., and A. Brunzell. 1977. Estimation of particle size in medical aerosols with a cascade impactor. Acta Pharm. 14:95-104.
25. Clay, M.M., D. Pavia, S.P. Newman, T. Lennard-Jones, and S.W. Clarke. 1983. Assessment of jet nebulizers for lung aerosol therapy. Lancet I:592-594.
26. Stahlhofen, W., J. Gebhart, and J. Heyder. 1980. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am. Ind. Hyg. Assoc. J. 41:385-398a.
27. Consensus Conference on Aerosol Delivery. American Respiratory Care Foundation and American Association for Respiratory Care. 1991. Aerosol Consensus Statement. Chest 100:1106-1109.
28. Thorsson, L., S. Edsbacker, and T.B. Conradson. 1994. Lung deposition of Budesonide from Turbohaler is twice that from pressurised meter dose inhaler (P-MDI). Eur. Respir. J. 7:1839-1844.
29. Borgstrom, L., E. Derom, E. Stahl, E. Wahlin-Boll, and R. Pauwels. 1996. The inhalation device influences lung deposition and bronchodilating effect of Terbutaline. Am. J. Respir. Crit. Care Med. 153:1636-1640.
30. Tal, A., H. Golan, N. Grauer, M. Aviram, D. Alvin, and M.R. Quastel. 1996. Deposition pattern of radiolabeled Salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J. Pediatr. 128:479-484.
31. Everard, M.L., A.R. Clark, and A. Miller. 1992. Drug delivery from jet nebulizers. Arch Dis Child. 67:586-591.
32. Dahlback, M. 1994. Behavior of nebulizing solutions and suspensions. J. Aerosol Med. 7(Suppl 1):S13-S18.
33. Schreier, H., R.J. Gonzalez-Rothi, and A.A. Stecenko. 1993. Pulmonary delivery of liposomes. J. Controlled Release 24:209-223.
34. Waldrep, J.C., K. Keyhani, M. Black, and V. Knight. 1994. Operating characteristics of 18 continuous-flow jet nebulizers Beclomethasone Dipropionate liposome aerosol. Chest 105:106-110.
35. Mac Callion, O.N.M., K.M.G. Taylor, M. Thomas, and A.J. Taylor. 1996. Nebulization of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulizers. Int. J. Pharm. 133:203-214.
36. Vidgren, M., J.C. Waldrep, J. Arppe, M. Black, J.A. Rodarte, W. Cole, and Vv. Knight. 1994. A study of 99m Technesium-Labeled Beclomethasone Dipropionate Dilauroylphosphatidilcholine liposome aerosol in normal volunteers. Int. J. Pharm. 115:209-216.
37. Newman, S.P., N. Talaee, K. Nikander, E. Berg, and S.W. Clarke. 1988. Evaluation of nebulizers and compressors for use with Budesonide nebulizer suspension. Eur. Respir. J. 1(suppl 2):211s.
38. Clay, M.M., D. Pavia, S.P. Newman, and S.W. Clarke. 1983. Factors influencing the size distribution of aerosols from jet nebulizers. Thorax 38:755-759.
39. Newman, S.P., P.G.D. Pellow, and S.W. Clarke. 1986. Droplet size distributions of nebulized aerosols for inhalation therapy. Clin. Phys. Physiol. Meas. 7(2):139-146.
40. Waldrep, J.C., M.T. Vidgren, A. Palander, M.T. Black, and V. Knight. 1994. Analysis of glucocorticoid-liposome & microcrystalline suspension aerosol formulations. Am. J. Respir. Crit. Care Med. 149(4, Part 2 of 2):A220.
41. Smith, E.C., J. Denyer, and A.H. Kendrik. 1995. Comparison of twenty three nebulizer/compressor combinations for domiciliary use. Eur. Respir. J. 8:1214-1221.
42. Dennis, J.H. 1995. Drug nebulizer design and performance: Breath enhanced jet vs. constant output jet ultrasonic. J. Aerosol Med. 8(3):277-280.
43. Loffert, D.T., D. Ikle, and H.S. Nelson. 1994. A comparison of commercial jet nebulizers. Chest 106:1788-1793.
44. Waldrep, J.C., B.E. Gilbert, C.M., Knight, M. Black, P. Scherer, V. Knight, and W. Eschenbacher. 1997. Pulmonary delivery of Beclomethasone liposome aerosol in volunteers. Chest 111:316-323.